Credit Suisse’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-227,953
Closed -$1.32M 4381
2019
Q2
$1.32M Buy
+227,953
New +$1.5M ﹤0.01% 2747
2017
Q4
Sell
-168,677
Closed -$1.88M 4338
2017
Q3
$1.88M Sell
168,677
-737,437
-81% -$8.63M ﹤0.01% 2600
2017
Q2
$8.59M Sell
906,114
-232,560
-20% -$1.86M 0.01% 1290
2017
Q1
$7.58M Sell
1,138,674
-18,365
-2% -$109K 0.01% 1364
2016
Q4
$7.08M Buy
1,157,039
+173,253
+18% +$863K 0.01% 1415
2016
Q3
$5.03M Sell
983,786
-46,943
-5% -$250K ﹤0.01% 1649
2016
Q2
$5.93M Buy
1,030,729
+51,207
+5% +$312K 0.01% 1509
2016
Q1
$5.95M Buy
979,522
+198,486
+25% +$1.19M 0.01% 1412
2015
Q4
$4.97M Buy
781,036
+555,124
+246% +$3.5M 0.01% 1580
2015
Q3
$1.36M Buy
225,912
+89,720
+66% +$558K ﹤0.01% 2551
2015
Q2
$839K Buy
+136,192
New +$836K ﹤0.01% 3333

Other funds holding CO

Credit Suisse's CO Position: Q3 2019 in Review

Credit Suisse sold out of Global Cord Blood Corporation (CO) in Q3 2019, closing a stake of 227,953 shares — an estimated $1.32M sold.

Credit Suisse first reported a position in CO in Q2 2015 and held it in 11 quarters. The position peaked at $8.59M in Q2 2017. 44 funds tracked by Wall St. Rank hold CO as of Q3 2019.

  • Credit Suisse reported no remaining Global Cord Blood Corporation position as of Q3 2019 after selling out during the quarter.
  • Credit Suisse sold 227,953 Global Cord Blood Corporation shares in Q3 2019, an estimated $1.32M.
  • Credit Suisse first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 11 quarters.
  • Credit Suisse's Global Cord Blood Corporation position peaked at $8.59M in Q2 2017.
  • 44 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.